cornea disease

Building on cyclosporine for dry eyeA phase II study investigating a novel topical cyclosporine product (CyclASol, Novaliq) formulated in a semifluorinated alkane (SFA) vehicle showed promising efficacy, safety, and tolerability. Planning is ongoing for the phase III trial of cyclosporine in the SFA technology.
Rituximab appears to cure Mooren’s ulcers in 5 patientsMooren’s ulcers completely healed in 5 patients treated with rituximab after conventional treatment failed, according to researchers.
Protein agent may change approach to treating dry eye, inflammationRecombinant human lubricin showed potential as a new therapeutic approach to the management of dry eye disease in a small clinical trial. Compared with sodium hyaluronate, lubricin (Lubris BioPharma), significantly improved both signs and symptoms of moderate dry eye after two weeks of treatment.
Irritation in a bottle: Glaucoma and OSDOSD is of significant concern in patients with glaucoma on multiple topical medications. Optimal treatment of this condition with minimizing the intensity as well as with additional pharmacologic treatments for OSD can improve visual acuity and compliance and result in better outcomes both medically and regarding patient satisfaction.
Nepal institute pioneers corneal donation programmeNepal’s Tilganga Institute of Ophthalmology has been working to build one of the most successful corneal donation programmes in the world.
Pre-existing glaucoma poses considerations for corneal proceduresPatients with pre-existing glaucoma require special consideration before performing a corneal procedure.
Photoactivation holds promise for keratitis treatment
Photoactivation holds promise for keratitis treatmentThe same photoactivation process used in collagen cross-linking for keratoconus can kill bacteria without the need for the oxygen responsible for the biomechanical effects, potentially pointing toward better treatments for keratitis, according to Olivier Richoz, MD, PhD.
Toric IOLs in abnormal corneas: How the two can work togetherPremium IOLs can be used successfully in patients with corneal pathologies.